The indispensability of macrophage adaptor proteins in chronic inflammatory diseases.
Atre R, Sharma R, Vadim G, Solanki K, Wadhonkar K, Singh N, Patidar P, Khabiya R, Samaur H, Banerjee S, Baig MS.
Publications
Publications Link :
Dorzolamide suppresses PKCĪ“ -TIRAP-p38 MAPK signaling axis to dampen the inflammatory response.
Rajpoot S, Kumar A, Gaponenko V, Thurston TL, Mehta D, Faisal SM, Zhang KY, Jha HC, Darwhekar GN, Baig MS.
Lipids and inflammation in health and disease.
Bezsonov E, Baig MS, Bukrinsky M, Myasoedova V, Ravani A, Sukhorukov V, Zhang D, Khotina V, Orekhov A.
Nirmatrelvir exerts distinct antiviral potency against different human coronaviruses.
Li J, Wang Y, Solanki K, Atre R, Lavrijsen M, Pan Q, Baig MS, Li P.
Anti-lung cancer properties of cyanobacterial bioactive compounds.
Baig MS, Rajpoot S, Ohishi T, Savai R, Seidel S, Kamennaya NA, Bezsonov EE, Orekhov AN, Mahajan P, Solanki K, Saqib U.
Structural analysis of spike proteins from SARS-CoV-2 variants of concern highlighting their functional alterations.
Solanki K, Rajpoot S, Kumar A, J Zhang KY, Ohishi T, Hirani N, Wadhonkar K, Patidar P, Pan Q, Baig MS.
Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2.
Ohishi T, Hishiki T, Baig MS, Rajpoot S, Saqib U, Takasaki T, Hara Y.
The expanding roles of neuronal nitric oxide synthase (NOS1).
Solanki K, Rajpoot S, Bezsonov EE, Orekhov AN, Saluja R, Wary A, Axen C, Wary K, Baig MS.
Repurposing dyphylline as a pan-coronavirus antiviral therapy.
Wang Y, Rajpoot S, Li P, Lavrijsen M, Ma Z, Hirani N, Saqib U, Pan Q, Baig MS.
TIRAP-mediated activation of p38 MAPK in inflammatory signaling.
Rajpoot S, Kumar A, Zhang KYJ, Gan SH, Baig MS
Differing pan-coronavirus antiviral potency of boceprevir and GC376 in vitro despite discordant molecular docking predictions.
Wang Y, Li P, Lavrijsen M, Li Y, Ma Z, Peppelenbosch MP, Baig MS, Pan Q.
Identification of novel inhibitors targeting TIRAP interactions with BTK and PKCĪ“ in inflammation through an in silico approach.
Rajpoot S, Srivastava G, Siddiqi MI, Saqib U, Parihar SP, Hirani N, Baig MS.
In-Silico Design of a Novel Tridecapeptide Targeting Spike Protein of SARS-CoV-2 Variants of Concern.
Rajpoot S, Solanki K, Kumar A, Zhang KYJ, Pullamsetti SS, Savai R, Faisal SM, Pan Q, Baig MS.
Comparative assessment of favipiravir and remdesivir against human coronavirus NL63 in molecular docking and cell culture models.
Wang Y, Li P, Rajpoot S, Saqib U, Yu P, Li Y, Li Y, Ma Z, Baig MS, Pan Q.
Viral polymerase binding and broad-spectrum antiviral activity of molnupiravir against human seasonal coronaviruses.
Wang Y, Li P, Solanki K, Li Y, Ma Z, Peppelenbosch MP, Baig MS, Pan Q.